Fri. Oct 7th, 2022
Diabetic Peripheral Neuropathy epidemiology

DelveInsight launched a new report on Diabetic Peripheral Neuropathy Epidemiology Forecast, 2030.

Diabetic peripheral neuropathy (DPN) also known Distal symmetric polyneuropathy (DSPN) is defined as the  symptoms and/or signs of peripheral nerve dysfunction and nerve damage in diabetic patients after the exclusion of  other causes. It is a predominantly sensory neuropathy with autonomic nervous system involvement, although there  are often motor features with advancing disease.

It is a common prevalent complication in neurological damage of Type 1 and Type 2 diabetes. It is typically characterized by significant deficits in tactile sensitivity, vibration sense, lower-limb proprioception, and kinesthesia. Painful DPN has been shown to be associated with significant reductions in overall quality of life, increased levels of anxiety and depression, sleep impairment, and greater gait variability.

DelveInsight’s ‘Diabetic Peripheral Neuropathy Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Diabetic Peripheral Neuropathy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key highlights from the Diabetic Peripheral Neuropathy Epidemiology Report:

  1. According to DelveInsight estimates, the total diagnosed prevalent population of Diabetic  Peripheral Neuropathy in 7MM was found to  be 25,507,330 in 2018.
  2. Among the EU5 countries, Germany had the  highest prevalent cases with 3,924,253   cases in 2018. 
  3. Among all the countries, the United States has a higher  prevalent population of DPN with 12,633,933 cases in  2018.
  4. Among the EU5 countries, Germany has the highest prevalent cases followed by Italy and Spain.  The UK accounted for the least number of cases for DPN in 2018
  5. Japan accounted for 3,259,231 cases of Diabetic Peripheral Neuropathy in 2018.

Visit for more @ Diabetic Peripheral Neuropathy Epidemiology Insights

Scope of the Diabetic Peripheral Neuropathy Epidemiology report:

  1. The Diabetic Peripheral Neuropathy report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
  2. The Diabetic Peripheral Neuropathy Epidemiology Report and Model provide an overview of the risk factors and global trends of Diabetic Peripheral Neuropathy in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  3. The report provides insight into the historical and forecasted patient pool of Diabetic Peripheral Neuropathy in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  4. The report helps to recognize the growth opportunities in the 7MM concerning the patient population
  5. The report assesses the disease risk and burden and highlights the unmet needs of Diabetic Peripheral Neuropathy
  6. The report provides the segmentation of the Diabetic Peripheral Neuropathy epidemiology

Table of Contents:

  1. Key Insights
  2. Executive Summary of Diabetic Peripheral Neuropathy
  3. Diabetic Peripheral Neuropathy Epidemiology Overview at a Glance
  4. Diabetic Peripheral Neuropathy: Disease Background and Overview
  5. Epidemiology and Patient Population
  6. Case Reports
  7. Country Wise-Epidemiology of Diabetic Peripheral Neuropathy 
  8. Appendix
  9. DelveInsight Capabilities
  10. Disclaimer
  11. About DelveInsight

Read more on Diabetic Peripheral Neuropathy Epidemiological Insights

Related Reports:

Diabetic Peripheral Neuropathy Market

Diabetic Peripheral Neuropathy Pipeline 

Latest Reports by DelveInsight

McCune-Albright Syndrome Market

Metastatic Conventional Chondrosarcoma Market

Metastatic Cutaneous Melanoma Market

Mismatch Repair Deficiency Market

Motor Neuron Disease Market

Myotubular Myopathy Market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Kritika Rehani

Email: [email protected]

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com

 

By sthakur

Leave a Reply

Your email address will not be published. Required fields are marked *